0 votes
in Allergy
Is sublingual immunotherapy FDA approved?

1 Answer

0 votes
FDA approves sublingual immunotherapy for dust mite allergies. The Food and Drug administration has approved a sublingual immunotherapy to treat nasal inflammation caused by dust mite allergy. The tablets offer an alternative to subcutaneous injections, the FDA said in a statement issued March 1.
...